Clinical trial
Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance and Postprandial Endothelial Function.
NCT01839344 is registered in ClinicalTrials.gov with Bastyr University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance and Postprandial Endothelial Function.
- Lead sponsor
- Bastyr University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- March 31, 2015
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.